Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Controversy about the cardiovascular safety of sibutramine.

× No keyword cloud information.

21 in total

Review 1. Safety of obesity drugs.

Authors: Frank L Greenway; Mary K Caruso
Journal: Expert Opin Drug Saf Date: 2005-11 Impact factor: 4.250

2. Assessing the cardiovascular safety of diabetes therapies.

Authors: Allison B Goldfine
Journal: N Engl J Med Date: 2008-09-11 Impact factor: 91.245

3. Sibutramine: balancing weight loss benefit and possible cardiovascular risk.

Authors: Giovanni de Simone; Gianpaolo D'Addeo
Journal: Nutr Metab Cardiovasc Dis Date: 2008-05-27 Impact factor: 4.222

4. Fatal and non-fatal cardiovascular events in a general population prescribed sibutramine in New Zealand: a prospective cohort study.

Authors: Mira Harrison-Woolrych; Janelle Ashton; Peter Herbison
Journal: Drug Saf Date: 2010-07-01 Impact factor: 5.606

Review 5. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.

Authors: Paul Poirier; Thomas D Giles; George A Bray; Yuling Hong; Judith S Stern; F Xavier Pi-Sunyer; Robert H Eckel
Journal: Circulation Date: 2005-12-27 Impact factor: 29.690

6. Body-mass index and mortality in a prospective cohort of U.S. adults.

Authors: E E Calle; M J Thun; J M Petrelli; C Rodriguez; C W Heath
Journal: N Engl J Med Date: 1999-10-07 Impact factor: 91.245

7. Obesity and trends in cardiovascular risk factors over 40 years in Swedish men aged 50.

Authors: A Rosengren; H Eriksson; P O Hansson; K Svärdsudd; L Wilhelmsen; S Johansson; C Welin; L Welin
Journal: J Intern Med Date: 2009-04-07 Impact factor: 8.989

Review 8. A benefit-risk assessment of sibutramine in the management of obesity.

Authors: Enzo Nisoli; Michele O Carruba
Journal: Drug Saf Date: 2003 Impact factor: 5.606

9. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors: Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal: N Engl J Med Date: 2007-06-07 Impact factor: 91.245

10. Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults.

Authors: M O'Flaherty; E Ford; S Allender; P Scarborough; S Capewell
Journal: Heart Date: 2007-07-19 Impact factor: 5.994

1 in total

1. The effect of sibutramine prescribing in routine clinical practice on cardiovascular outcomes: a cohort study in the United Kingdom.

Authors: J F Hayes; K Bhaskaran; R Batterham; L Smeeth; I Douglas
Journal: Int J Obes (Lond) Date: 2015-05-14 Impact factor: 5.095

1 in total